Abstract
Pre-implantation genetic testing for aneuploidy (PGT-A) has been used to allow the transfer of a euploid embryo to achieve a higher chance of pregnancy. Currently, PGT-A is offered to IVF patients on a self-pay basis, even in states with a legislative mandate to cover infertility treatment. It is unclear if PGT-A improves clinical pregnancy rates if the cycle yields only one blastocyst of sufficient quality to biopsy and cryopreserve. The objective of this study was to determine if there is any difference in clinical pregnancy rates between patients with a single freezable blastocyst who undergo PGT-A compared to those who undergo transfer of a single untested blastocyst.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
